REQUEST A DEMO
Total
USD $0.00
Search more companies

Sanera Ecza Deposu Ve Dis Ticaret A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sanera Ecza Deposu Ve Dis Ticaret Anonim Sirketi Profile Updated: May 07, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

sanera pharmaceuticals & research is a pharmaceutical wholesaler based in Istanbul, Turkey. The company operates in the pharmaceutical export industry, supplying multinational branded medicines, generic medicines, and OTC products to over 70 countries. sanera pharmaceuticals & research offers transportation solutions and services such as regulatory affairs, logistics, and distribution. The company claims to have a presence in the Gulf region, serving countries such as Saudi Arabia, Bahrain, Qatar, Iraq, Kuwait, UAE, Iran, and Oman.

Headquarters
No:38a-1 Serifali Mahallesi Yunus Sokak Umraniye
Istanbul; Marmara; Postal Code: 34775

Contact Details: Purchase the Sanera Ecza Deposu Ve Dis Ticaret A.S. report to view the information.

Website: http://www.sanerapharma.com

Basic Information
Total Employees:
Purchase the Sanera Ecza Deposu Ve Dis Ticaret A.S. report to view the information.
Outstanding Shares:
Purchase the Sanera Ecza Deposu Ve Dis Ticaret A.S. report to view the information.
Incorporation Date:
September 01, 2014
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Sanera Ecza Deposu Ve Dis Ticaret A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
108.19%
Total operating revenue
108.19%
Operating profit (EBIT)
240.39%
Net Profit (Loss) for the Period
381.69%
Total assets
195.16%
Total equity
10.9%
Operating Profit Margin (ROS)
1.66%
Net Profit Margin
0.97%
Return on Equity (ROE)
30.8%
Quick Ratio
-0.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?